Merck & Co. Inc. (NYSE:MRK)

Current assets exhibited a generally increasing trend over the five-year period. Initial growth was followed by a slight decrease, then resumed an upward trajectory, culminating in the highest value in 2025. Adjusted current assets mirrored this pattern, consistently exceeding reported current assets and demonstrating a similar growth profile.

Overall Trend

Both current assets and adjusted current assets increased from 2021 to 2025. Current assets grew from US$30,266 million in 2021 to US$43,516 million in 2025, representing a 43.8% increase. Adjusted current assets experienced a similar increase, moving from US$30,344 million to US$44,525 million, a 46.8% rise.

Year-over-Year Changes

From 2021 to 2022, both metrics showed substantial growth. Current assets increased by 18.0%, while adjusted current assets rose by 18.9%. A decrease was observed from 2022 to 2023, with current assets declining by 10.2% and adjusted current assets by 9.3%. However, growth resumed from 2023 to 2024, with increases of 20.6% for current assets and 21.0% for adjusted current assets. The most significant growth occurred between 2024 and 2025, with current assets increasing by 12.2% and adjusted current assets by 12.3%.

Difference Between Metrics

Adjusted current assets consistently exceeded current assets throughout the period. The difference between the two values remained relatively stable, ranging from approximately US$78 million to US$1,009 million. This suggests that the adjustments made to current assets are systematic and do not represent large, fluctuating corrections.

The consistent upward trend in both current asset figures suggests a strengthening financial position over the analyzed period. The adjustments applied to current assets appear to be consistently applied, resulting in a parallel increase in the adjusted value. The dip in 2023 warrants further investigation to understand the underlying factors contributing to the temporary decline.

Total assets exhibited a generally increasing trend over the five-year period, though with some fluctuation. Reported total assets grew from US$105,694 million in 2021 to US$136,866 million in 2025. However, a decrease was observed between 2021 and 2023 before a more substantial increase occurred in subsequent years. Adjusted total assets mirrored this pattern, demonstrating a similar trajectory and magnitude of change.

Overall Trend

Both total assets and adjusted total assets generally increased from 2021 to 2025. The growth was not linear, with a dip in 2023 for both metrics. The most significant increase in both metrics occurred between 2023 and 2025.

Year-over-Year Changes

From 2021 to 2022, total assets increased by US$3,466 million, and adjusted total assets increased by US$3,942 million. A decrease was then noted from 2022 to 2023, with total assets declining by US$2,485 million and adjusted total assets by US$3,665 million. The period from 2023 to 2024 saw a recovery, with total assets increasing by US$10,431 million and adjusted total assets by US$8,077 million. The largest year-over-year increase occurred from 2024 to 2025, with total assets growing by US$19,760 million and adjusted total assets by US$21,406 million.

Relationship between Total and Adjusted Assets

The difference between total assets and adjusted total assets remained relatively consistent throughout the period. The adjusted figures were consistently lower than the reported total assets, suggesting the adjustments relate to items reducing the reported value. The magnitude of the adjustment ranged from approximately US$614 million to US$1,586 million annually.

The substantial increases observed in both total and adjusted assets in the later years of the period warrant further investigation to determine the underlying drivers of this growth. The consistent difference between the two figures suggests a recurring pattern of adjustments that should be examined to understand their nature and impact on the financial position.

Total liabilities exhibited fluctuations over the five-year period. Initially decreasing from 2021 to 2022, they subsequently increased through 2025. A parallel set of adjusted total liabilities demonstrates a similar pattern, though with differing magnitudes of change.

Overall Trend

From 2021 to 2022, total liabilities decreased from US$67,437 million to US$63,102 million, representing a decline of approximately 6.4%. This was followed by increases in subsequent years, reaching US$84,204 million in 2025. Adjusted total liabilities mirrored this trend, decreasing from US$63,359 million in 2021 to US$60,794 million in 2022, and then increasing to US$81,469 million in 2025.

Magnitude of Change

The largest single-year increase in total liabilities occurred between 2024 and 2025, with an addition of US$13,470 million. The increase between 2023 and 2024 was US$1,694 million. The adjusted total liabilities experienced its largest increase between 2024 and 2025 as well, with an addition of US$12,686 million. The increase between 2023 and 2024 was US$1,326 million.

Relationship between Total and Adjusted Liabilities

The difference between total liabilities and adjusted total liabilities remained relatively consistent throughout the period. In each year, adjusted total liabilities were lower than total liabilities, suggesting the adjustments represent items that are not consistently recognized or are subject to reclassification. The gap between the two values widened slightly from US$4,078 million in 2021 to US$2,735 million in 2025.

The consistent pattern of adjustments suggests these are not isolated events but rather ongoing differences in the recognition or valuation of certain liabilities. Further investigation into the nature of these adjustments would be necessary to fully understand their impact on the financial position.

Total stockholders’ equity exhibited volatility over the five-year period. Initially increasing from 2021 to 2022, it then decreased in 2023 before recovering and continuing to grow through 2025. The adjusted total equity mirrors this pattern, though the magnitudes of change differ. A comparison of the two equity figures reveals consistent adjustments impacting the reported value.

Overall Trend

Both total and adjusted stockholders’ equity generally trended upwards between 2021 and 2025, despite an interim decline in 2023. The adjusted equity consistently reports a higher value than the total equity, suggesting the presence of adjustments that increase the reported equity position.

Growth Rates

From 2021 to 2022, total stockholders’ equity increased by approximately 20.4%. Adjusted equity experienced a similar increase of approximately 15.4% over the same period. The decline in 2023 saw total equity decrease by roughly 18.2%, while adjusted equity fell by approximately 17.7%. The subsequent recovery from 2023 to 2024 showed increases of 23.2% for total equity and 21.2% for adjusted equity. Finally, from 2024 to 2025, total equity grew by 14.8%, and adjusted equity increased by 16.3%.

Adjustment Impact

The difference between total and adjusted equity remained relatively stable over the period, fluctuating between approximately US$3.5 billion and US$4.0 billion. In 2021, the adjustment added roughly 9.3% to the reported equity. In 2022, the adjustment represented approximately 4.8% of total equity. In 2023, the adjustment was approximately 0.4% of total equity. In 2024, the adjustment was approximately 2.2% of total equity. In 2025, the adjustment was approximately 1.9% of total equity. This suggests the nature or magnitude of the adjustments may have shifted over time.

The fluctuations in both total and adjusted equity warrant further investigation to understand the underlying drivers. The consistent presence of adjustments indicates that factors beyond retained earnings and common stock transactions are influencing the reported equity position. A detailed review of the nature of these adjustments is recommended.

Over the five-year period ending December 31, 2025, both reported and adjusted financial metrics demonstrate notable fluctuations. Total reported debt initially decreased between 2021 and 2022, then increased consistently through 2025, exhibiting the largest increase between 2024 and 2025. Stockholders’ equity followed a different pattern, increasing from 2021 to 2022, decreasing in 2023, and then increasing again through 2025. Total reported capital mirrored the debt trend, with a consistent increase over the period, accelerating in the final two years.

Debt Trends

Reported total debt decreased from US$33,102 million in 2021 to US$30,691 million in 2022, representing a 7.3% decline. Subsequently, debt increased to US$35,055 million in 2023, US$37,111 million in 2024, and reached US$49,339 million in 2025, a substantial 33.2% increase from 2024. The adjusted total debt followed a similar trajectory, with a comparable percentage change between years.

Equity Trends

Total Merck & Co., Inc. stockholders’ equity increased by 20.7% from US$38,184 million in 2021 to US$45,991 million in 2022. A decrease was observed in 2023, falling to US$37,581 million, before recovering to US$46,313 million in 2024 and further increasing to US$52,606 million in 2025. Adjusted total equity exhibited a similar pattern, though the magnitudes of change differed slightly.

Capital Structure

Total reported capital increased from US$71,286 million in 2021 to US$101,945 million in 2025, representing a 42.8% increase over the period. The adjusted total capital also increased, moving from US$76,352 million in 2021 to US$104,335 million in 2025, a 36.7% increase. The difference between reported and adjusted capital remained relatively consistent throughout the period, suggesting systematic adjustments are being applied.

The adjustments to both debt and equity resulted in slightly higher values for adjusted total capital compared to reported total capital in each year. The magnitude of these adjustments remained relatively stable over the observed period. The significant increase in both reported and adjusted debt in 2025 warrants further investigation to understand the underlying reasons, such as potential acquisitions, increased borrowing, or changes in financing strategies.

The reported net income attributable to Merck & Co., Inc. demonstrates significant fluctuation over the five-year period. Initial growth from 2021 to 2022 is followed by a substantial decline in 2023, with subsequent recovery and continued growth in 2024 and 2025. However, the adjusted net income presents a different pattern, exhibiting less consistent growth and a notable negative value in 2023.

Net Income Trend

Net income increased from US$13,049 million in 2021 to US$14,519 million in 2022, representing a growth of approximately 11.3%. A dramatic decrease occurred in 2023, with net income falling to US$365 million. This represents a decline of approximately 97.5% from the prior year. Net income then rebounded strongly in 2024 to US$17,117 million, and continued to grow to US$18,254 million in 2025.

Adjusted Net Income Trend

Adjusted net income began at US$14,282 million in 2021, decreasing to US$12,782 million in 2022, a decline of approximately 10.5%. The most significant observation is the negative adjusted net income of US$-1,431 million in 2023. This indicates substantial adjustments were made that reduced reported net income below zero. Adjusted net income recovered to US$16,231 million in 2024 and further increased to US$18,062 million in 2025, though the growth rate appears to be moderating compared to the recovery from 2023.

Relationship Between Reported and Adjusted Income

The difference between reported net income and adjusted net income varies considerably. In 2021 and 2022, adjusted net income was higher than reported net income. However, in 2023, the divergence is extreme, with adjusted net income being significantly negative while reported net income remained positive, albeit at a very low level. This suggests the presence of substantial one-time or non-recurring items impacting the adjusted figures in 2023. The gap narrows in 2024 and 2025, with adjusted and reported net income converging, but remaining distinct.

The substantial fluctuations in both reported and adjusted net income, particularly the negative adjusted net income in 2023, warrant further investigation to understand the underlying drivers of these adjustments and their impact on the company’s financial performance.